Welcome to CDC Stacks | Unusual donor derived transplant-associated Infections : just how unusual? - 26058 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Unusual donor derived transplant-associated Infections : just how unusual?
  • Published Date:
    November 18, 2014
  • Language:
    English
Filetype[PDF - 4.64 MB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.) ;
  • Description:
    Supply and Demand for Organ Transplantation in the United States [PDF version of the PowerPoint presentation by Robert Walsh, p. 2-11] -- Current Screening of Organ Donors for Donor-derived Infections [PDF version of the PowerPoint presentation by Daniel Kaul, p. 12-24] -- The Role of Public Health and Pathology in Detecting Emerging Transplant-associated Infections [PDF version of the PowerPoint presentation by Sherif R. Zaki, p. 25-59] -- Preventing Unusual Transplant-associated Infections” [PDF version of the PowerPoint presentation by Sridhar V. Basavaraju, p. 60-70].

    In 2013, 28,955 organ transplants were performed in this country. Of these, 22,967 were conducted using organs procured from deceased donors. As impressive as this number may seem, the demand is even greater, with over 123,000 people currently awaiting an organ transplant. The Organ Procurement and Transplantation Network, or OPTN, attempts to increase the number of and access to transplants while working to reduce the risk of transmission of disease from organ donors to recipients. While some organ transplantations are life-saving procedures, serious illness and death can occur from undetected infections in donor organs and tissues.

    Transplant centers have very little time to evaluate if the need for transplant for a particular recipient outweighs the possible risk of infection from a potential donor. In the case of transplants from deceased donors, time and other factors limit the testing that can be performed prior to transplant and for each donor there is the potential to infect multiple recipients. In addition to laboratory testing, all potential deceased donors undergo a medical risk assessment to screen for potential infectious agents. However, complete and accurate information can be very difficult to obtain at the time of organ donation. Over the past decade, new efforts in surveillance, detection, and screening of health risks have been employed to make transplants safer and to ensure that recipients have the best outcomes possible.

    Join us for this session of Public Health Grand Rounds as we present some of the common themes that have emerged in unusual transplant-transmitted infections. Specifically, we will hear about the work that CDC and partners in the organ transplantation community are actively doing to further reduce the risk of unusual transplant-associated infections.

    Public Health Grand Rounds held on Tuesday, November 18, 2014, at 1pm EST.

    Presented by: Robert Walsh, Director, Division of Transplantation, Healthcare Systems Bureau, Health Resources and Services Administration [“Supply and Demand for Organ Transplantation in the United States”]; Daniel Kaul, MD, Director, Transplant Infectious Disease Services, University of Michigan, Chair, Disease Transmission Advisory Committee, United Network for Organ Sharing [“Current Screening of Organ Donors for Donor-derived Infections”]; Sherif R. Zaki, MD, PhD, Chief, Infectious Diseases Pathology Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC [“The Role of Public Health and Pathology in Detecting Emerging Transplant-associated Infections”]; Sridhar V. Basavaraju, MD, Commander, U. S. Public Health Service, Medical Officer, Office of Blood, Organ, and Other Tissue Safety, National Center for Emerging and Zoonotic Infectious Diseases, CDC [“Preventing Unusual Transplant-associated Infections”].

    Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds.

  • Document Type:
  • Place as Subject:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: